相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Expression of the PTEN/FOXO3a/PLZF signalling pathway in pancreatic cancer and its significance in tumourigenesis and progression
Qiubo Zhang et al.
INVESTIGATIONAL NEW DRUGS (2020)
Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer
Miriam Kokal et al.
CANCERS (2020)
The triphenyltin carboxylate derivative triphenylstannyl 2-(benzylcarbamoyl)benzoate impedes prostate cancer progression via modulation of Akt/FOXO3a signaling
Durdana Waseem et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2020)
Molecular characterization of autophagic and apoptotic signaling induced by sorafenib in liver cancer cells
Maria A. Rodriguez-Hernandez et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2019)
Evaluation of the anticancer and anti-metastasis effects of novel synthetic sodium channel blockers in prostate cancer cells in vitro and in vivo
Jiajia Wang et al.
PROSTATE (2019)
Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss
Johann S. de Bono et al.
CLINICAL CANCER RESEARCH (2019)
Targeted Regulation of miR-26a on PTEN to Affect Proliferation and Apoptosis of Prostate Cancer Cells
Weilu Li et al.
CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS (2019)
Synergistic Effects of Nobiletin and Sorafenib Combination on Metastatic Prostate Cancer Cells
Gamze Guney Eskiler et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2019)
TUBB3 Reverses Resistance to Docetaxel and Cabazitaxel in Prostate Cancer
Yohei Sekino et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Pharmacogenomic Biomarkers in Docetaxel Treatment of Prostate Cancer: From Discovery to Implementation
Reka Varnai et al.
GENES (2019)
FasL on the surface of Tag7 (PGRP-S)-activated lymphocytes induces necroptosis in HLA-negative tumor cells with the involvement of lysosomes and mitochondria
Tatiana N. Sharapova et al.
BIOCHIMIE (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
β-arrestin1-medieated inhibition of FOXO3a contributes to prostate cancer cell growth invitro and invivo
Zhenzhen Kong et al.
CANCER SCIENCE (2018)
Clinical implications of PTEN loss in prostate cancer
Tamara Jamaspishvili et al.
NATURE REVIEWS UROLOGY (2018)
Ophiopogonin D′, a Natural Product From Radix Ophiopogonis, Induces in Vitro and in Vivo RIPK1-Dependent and Caspase-Independent Apoptotic Death in Androgen-Independent Human Prostate Cancer Cells
Zongliang Lu et al.
FRONTIERS IN PHARMACOLOGY (2018)
Restoration of tumour-growth suppression in vivo via systemic nanoparticle-mediated delivery of PTEN mRNA
Mohammad Ariful Islam et al.
NATURE BIOMEDICAL ENGINEERING (2018)
Targeting the BRD4/FOXO3a/CDK6 axis sensitizes AKT inhibition in luminal breast cancer
Jingyi Liu et al.
NATURE COMMUNICATIONS (2018)
Clofoctol and sorafenib inhibit prostate cancer growth via synergistic induction of endoplasmic reticulum stress and UPR pathways
Lixia Fan et al.
CANCER MANAGEMENT AND RESEARCH (2018)
Saponins in pulses and their health promoting activities: A review
Balwinder Singh et al.
FOOD CHEMISTRY (2017)
Regulating the balance between necroptosis, apoptosis and inflammation by inhibitors of apoptosis proteins
Lazaros Vasilikos et al.
IMMUNOLOGY AND CELL BIOLOGY (2017)
Pharmacological treatment with inhibitors of nuclear export enhances the antitumor activity of docetaxel in human prostate cancer
Giovanni Luca Gravina et al.
ONCOTARGET (2017)
Combination of sorafenib and enzalutamide as a potential new approach for the treatment of castration-resistant prostate cancer
Hongxi Wu et al.
CANCER LETTERS (2017)
Killing cancer with platycodin D through multiple mechanisms
Muhammad Khan et al.
JOURNAL OF CELLULAR AND MOLECULAR MEDICINE (2016)
S-equol, a Secondary Metabolite of Natural Anticancer Isoflavone Daidzein, Inhibits Prostate Cancer Growth In Vitro and In Vivo, Though Activating the Akt/FOXO3a Pathway
Zongliang Lu et al.
CURRENT CANCER DRUG TARGETS (2016)
Insights into a Critical Role of the FOXO3a-FOXM1 Axis in DNA Damage Response and Genotoxic Drug Resistance
Gabriela Nestal de Moraes et al.
CURRENT DRUG TARGETS (2016)
Platycodin D, a metabolite of Platycodin grandiflorum, inhibits highly metastatic MDA-MB-231 breast cancer growth in vitro and in vivo by targeting the MDM2 oncogene
Ya Kong et al.
ONCOLOGY REPORTS (2016)
Prospective Study of Transcatheter Arterial Chemoembolization (TACE) with Ginsenoside Rg3 versus TACE Alone for the Treatment of Patients with Advanced Hepatocellular Carcinoma
Bo Zhou et al.
RADIOLOGY (2016)
Platycodin D potentiates proliferation inhibition and apoptosis induction upon AKT inhibition via feedback blockade in non-small cell lung cancer cells
Ting Li et al.
SCIENTIFIC REPORTS (2016)
Akt/PKB: one kinase, many modifications
Guillermo Risso et al.
BIOCHEMICAL JOURNAL (2015)
Homoharringtonine, a clinically approved anti-leukemia drug, sensitizes tumor cells for TRAIL-induced necroptosis
Stephan Philipp et al.
CELL COMMUNICATION AND SIGNALING (2015)
Non-Coding RNAs in Castration-Resistant Prostate Cancer: Regulation of Androgen Receptor Signaling and Cancer Metabolism
Jing-Wen Shih et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
Evaluation of in vivo responses of sorafenib therapy in a preclinical mouse model of PTEN-deficient of prostate cancer
Yutaka Yamamoto et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2015)
Inhibition of PI3Kβ Signaling with AZD8186 Inhibits Growth of PTEN-Deficient Breast and Prostate Tumors Alone and in Combination with Docetaxel
Urs Hancox et al.
MOLECULAR CANCER THERAPEUTICS (2015)
Platycodin D Induces Tumor Growth Arrest by Activating FOXO3a Expression in Prostate Cancer in vitro and in vivo
Rui Zhou et al.
CURRENT CANCER DRUG TARGETS (2014)
Apigenin inhibits prostate cancer progression in TRAMP mice via targeting PI3K/Akt/FoxO pathway
Sanjeev Shukla et al.
CARCINOGENESIS (2014)
Role of Sorafenib in Overcoming Resistance of Chemotherapy-Failure Castration-Resistant Prostate Cancer
Andrew Meyer et al.
CLINICAL GENITOURINARY CANCER (2014)
BIM upregulation and ROS-dependent necroptosis mediate the antitumor effects of the HDACi Givinostat and Sorafenib in Hodgkin lymphoma cell line xenografts
S. L. Locatelli et al.
LEUKEMIA (2014)
Effects of Platycodin D on Proliferation, Apoptosis and PI3K/Akt Signal Pathway of Human Glioma U251 Cells
Chong Xu et al.
MOLECULES (2014)
Platycodin D, a triterpenoid saponin from Platycodon grandiflorum, induces G2/M arrest and apoptosis in human hepatoma HepG2 cells by modulating the PI3K/Akt pathway
Hua Qin et al.
TUMOR BIOLOGY (2014)
Loss of PTEN Is Associated with Aggressive Behavior in ERG-Positive Prostate Cancer
Katri A. Leinonen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2013)
Punctuated Evolution of Prostate Cancer Genomes
Sylvan C. Baca et al.
CELL (2013)
Platycodin D inhibits migration, invasion, and growth of MDA-MB-231 human breast cancer cells via suppression of EGFR-mediated Ala and MAPK pathways
Jaemoo Chun et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2013)
New Strategies in Prostate Cancer: Translating Genomics into the Clinic
Himisha Beltran et al.
CLINICAL CANCER RESEARCH (2013)
Sorafenib and TRAIL have synergistic effect on hepatocellular carcinoma
Keichiro Nojiri et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2013)
Advancing Precision Medicine for Prostate Cancer Through Genomics
Sameek Roychowdhury et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
PTEN loss mediated Akt activation promotes prostate tumor growth and metastasis via CXCL12/CXCR4 signaling
M. Katie Conley-LaComb et al.
MOLECULAR CANCER (2013)
Evaluation of the Spermicidal and Contraceptive Activity of Platycodin D, a Saponin from Platycodon grandiflorum
Zongliang Lu et al.
PLOS ONE (2013)
Deregulation of FoxO3a accelerates prostate cancer progression in TRAMP mice
Sanjeev Shukla et al.
PROSTATE (2013)
Sorafenib decreases proliferation and induces apoptosis of prostate cancer cells by inhibition of the androgen receptor and Akt signaling pathways
Su Jung Oh et al.
ENDOCRINE-RELATED CANCER (2012)
A phase II study of sorafenib in combination with bicalutamide in patients with chemotherapy-naive castration resistant prostate cancer
Emma K. Beardsley et al.
INVESTIGATIONAL NEW DRUGS (2012)
The mutational landscape of lethal castration-resistant prostate cancer
Catherine S. Grasso et al.
NATURE (2012)
Akt, FoxO and regulation of apoptosis
Xinbo Zhang et al.
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH (2011)
Reciprocal Feedback Regulation of PI3K and Androgen Receptor Signaling in PTEN-Deficient Prostate Cancer
Brett S. Carver et al.
CANCER CELL (2011)
Loss of memory B cells during chronic HIV infection is driven by Foxo3a-and TRAIL-mediated apoptosis
Julien Van Grevenynghe et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
The multikinase inhibitor Sorafenib displays significant antiproliferative effects and induces apoptosis via caspase 3, 7 and PARP in B- and T-lymphoblastic cells
Catrin Schult et al.
BMC CANCER (2010)
The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations
Anna Dubrovska et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
ERK promotes tumorigenesis by inhibiting FOXO3a via MDM2-mediated degradation
Jer-Yen Yang et al.
NATURE CELL BIOLOGY (2008)
FOXOs, cancer and regulation of apoptosis
Z. Fu et al.
ONCOGENE (2008)
A clinical phase II study with sorafenib in patients with progressive hormone-refractory prostate cancer: a study of the CESAR Central European Society for Anticancer Drug Research-EWIV
S. Steinbild et al.
BRITISH JOURNAL OF CANCER (2007)
Complete loss of PTEN expression as a possible early prognostic marker for prostate cancer metastasis
Martine Schmitz et al.
INTERNATIONAL JOURNAL OF CANCER (2007)
PTEN function in normal and neoplastic growth
Lionel M. L. Chow et al.
CANCER LETTERS (2006)
FOXO transcription factors at the interface between longevity and tumor suppression
EL Greer et al.
ONCOGENE (2005)
Induction of androgen receptor expression by phosphatidylinositol 3-kinase/Akt downstream substrate, FOXO3a, and their roles in apoptosis of LNCaP prostate cancer cells *
L Yang et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Expression of the pro-apoptotic Bcl-2 family member Bim is regulated by the forkhead transcription factor FKHR-L1
PF Dijkers et al.
CURRENT BIOLOGY (2000)
分享论文
